Reverse genetics of influenza viruses - Applications in research and vaccine design

Monographs in Virology

Volumn 27, Issue , 2008, Pages 118-133

  Neumann, Gabriele ^a   Horimoto, Taisuke ^b   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ORTHOMYXOVIRIDAE;

EID: 50549104827     PISSN: 00770965     EISSN: 16623851     Source Type: Book Series    
DOI: 10.1159/000151612     Document Type: Article

References (90)

1. Wright PF, Neumann G, Kawaoka Y: Orthomyxoviruses; in Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds): Fields Virology. Philadelphia, Wolters Kluwer, Lippincott Willams & Wilkins, 2007, pp 1691-1740.
2. Palese P, Shaw M: Orthomyxoviridae: The Viruses and Their Replication; in Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds): Fields Virology. Philadelphia, Wolters Kluwer, Lippincott Willams & Wilkins, 2007, pp 1647-1689.
3. Luytjes W, Krystal M, Enami M, Pavin JD, Palese P: Amplification, expression, and packaging of foreign gene by influenza virus. Cell 1989;59:1107-1113.
4. Neumann G, Zobel A, Hobom G: RNA polymerase I-mediated expression of influenza viral RNA molecules. Virology 1994;202:477-479.
5. Zobel A, Neumann G, Hobom G: RNA polymerase I catalysed transcription of insert viral cDNA. Nucleic Acids Res 1993;21:3607-3614.
6. Neumann G, Watanabe T, Ito H, Watanabe S, Goto H, Gao P, Hughes M, Perez DR, Donis R, Hoffmann E, Hobom G, Kawaoka Y: Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci USA 1999;96:9345-9350.
7. Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG, Garcia-Sastre A: Rescue of influenza A virus from recombinant DNA. J Virol 1999;73: 9679-9682.
8. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG: A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 2000;97:6108-6113.
9. Neumann G, Fujii K, Kino Y, Kawaoka Y: An improved reverse genetics system for influenza A virus generation and its implications for vaccine production. Proc Natl Acad Sci USA 2005;102:16825-16829.
10. Hoffmann E, Mahmood K, Yang CF, Webster RG, Greenberg HB, Kemble G: Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci USA 2002;99:11411-11416.
11. Jackson D, Cadman A, Zurcher T, Barclay WS: A reverse genetics approach for recovery of recombinant influenza B viruses entirely from cDNA. J Virol 2002;76:11744-11747.
12. Muraki Y: Reverse genetics study of influenza C virus. Abstracts of the XIII International Congress of Virology, San Francisco 2005.
13. Muraki Y, Murata T, Takashita E, Matsuzaki Y, Sugawara K, Hongo S: A mutation on influenza C virus M1 protein affects virion morphology by altering the membrane affinity of the protein. J Virol 2007;81:8766-8773.
14. Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD: Recovery of an arenavirus entirely from RNA polymerase I/II-driven cDNA. Proc Natl Acad Sci USA 2006;103:4663-4668.
15. De Wit E, Spronken MI, Vervaet G, Rimmelzwaan GF, Osterhaus AD, Fouchier RA: A reverse-genetics system for Influenza A virus using T7 RNA polymerase. J Gen Virol 2007;88:1281-1287.
16. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N: Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 1998;279:393-396.
17. Claas EC, Osterhaus AD, Van Beek R, de Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG: Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998;351:472-477.
18. Claas EC, de Jong JC, Van Beek R, Rimmelzwaan GF, Osterhaus AD: Human influenza virus A/Hong Kong/156/97 (H5N1) infection. Vaccine 1998;16: 977-978.
19. Gao P, Watanabe S, Ito T, Goto H, Wells K, McGregor M, Cooley AJ, Kawaoka Y: Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J Virol 1999;73:3184-3189.
20. Lu X, Tumpey TM, Morken T, Zaki SR, Cox NJ, Katz JM: A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J Virol 1999;73: 5903-5911.
21. Hatta M, Gao P, Halfmann P, Kawaoka Y: Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001;293:1840-1842.
22. Fouchier RA, Schneeberger PM, Rozendaal FW, Broekman JM, Kemink SA, Munster V, Kuiken T, Rimmelzwaan GF, Schutten M, Van Doornum GJ, Koch G, Bosman A, Koopmans M, Osterhaus AD: Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004;101:1356-1361.
23. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y: Adaptation of an H7N7 equine influenza A virus in mice. J Gen Virol 2007;88:547-553.
24. Shinya K, Hamm S, Hatta M, Ito H, Ito T, Kawaoka Y: PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 2004;320: 258-266.
25. Massin P, van der Werf S, Naffakh N: Residue 627 of PB2 is a determinant of cold sensitivity in RNA replication of avian influenza viruses. J Virol 2001;75:5398-5404.
26. Naffakh N, Massin P, Escriou N, Crescenzo-Chaigne B, van der Werf S: Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A viruses. J Gen Virol 2000;5:1283-1291.
27. Salomon R, Franks J, Govorkova EA, Ilyushina NA, Yen HL, Hulse-Post DJ, Humberd J, Trichet M, Rehg JE, Webby RJ, Webster RG, Hoffmann E: The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med 2006;203:689-697.
28. Li Z, Chen H, Jiao P, Deng G, Tian G, Li Y, Hoffmann E, Webster RG, Matsuoka Y, Yu K: Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 2005;79:12058-12064.
29. Gabriel G, Dauber B, Wolff T, Planz O, Klenk HD, Stech J: The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sc USA 2005;102:18590-18595.
30. Seo SH, Hoffmann E, Webster RG: Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002;8:950-954.
31. Krug RM, Yuan W, Noah DL, Latham AG: Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1protein. Virology 2003;309:181-189.
32. Garcia-Sastre A: Antiviral response in pandemic influenza viruses. Emerg Infect Dis 2006;12:44-47.
33. Couceiro JN, Paulson JC, Baum LG: Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993;29:155-165.
34. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD: Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sc USA 2004;101: 4620-4624.
35. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 2006;440:435-436.
36. Van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T: H5N1 Virus attachment to lower respiratory tract. Science 2006;312:399.
37. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW, Guan Y, Peiris JS: Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007;13:147-149.
38. Yamada S, Suzuki Y, Suzuki T, Le MQ, Nidom CA, Sakai-Tagawa Y, Muramoto Y, Ito M, Kiso M, Horimoto T, Shinya K, Sawada T, Kiso M, Usui T, Murata T, Lin Y, Hay A, Haire LF, Stevens DJ, Russell RJ, Gamblin SJ, Skehel JJ, Kawaoka Y: Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 2006;444:378-382.
39. Baslr CF, Reid AH, Dybing JK, Janczewski TA, Fanning TG, Zheng H, Salvatore M, Perdue ML, Swayne DE, Garcia-Sastre A, Palese P, Taubenberger JK: Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci USA 2001;98:2746-2751.
40. Reid AH, Fanning TG, Janczewski TA, Taubenberger JK: Characterization of the 1918 'Spanish' influenza virus neuraminidase gene. Proc Natl Acad Sci USA 2000;97:6785-6790.
41. Reid AH, Fanning TG, Hultin JV, Taubenberger JK: Origin and evolution of the 1918 'Spanish' influenza virus hemagglutinin gene. Proc Natl Acad Sci USA 1999;96:1651-1656.
42. Reid AH, Fanning TG, Janczewski TA, McCall S, Taubenberger JK: Characterization of the 1918 'Spanish' influenza virus matrix gene segment. J Virol 2002;76:10717-10723.
43. Reid AH, Fanning TG, Janczewski TA, Lourens RM, Taubenberger JK: Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J Virol 2004;78:12462-12470.
44. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG: Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:889-893.
45. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Basler CF: Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci USA 2004;101:3166-3171.
46. Kobasa D, Takada A, Shinya K, Hatte M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y: Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 2004;431:703-707.
47. Tumpey TM, Garcia-Sastre A, Taubenberger JK, Palese P, Swayne DE, Pantin-Jackwood MJ, Schultz-Cherry S, Solorzano A, Van Rooijen N, Katz JM, Basler CF: Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice. J Virol 2005;79:14933-14944.
48. Tumpey TM, Basler CF, Aguilar PV, Zeng H, Solorzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, Garcia-Sastre A: Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005;310:77-80.
49. Kash JC, Tumpey TM, Proll SC, Carter V, Perwitasari O, Thomas MJ, Basler CF, Palese P, Taubenberger JK, Garcia-Sastre A, Swayne DE, Katze MG: Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006;443:578-581.
50. Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y: Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007:445: 319-323.
51. Glaser L, Stevens J, Zamarin D, Wilson IA, Garcia-Sastre A, Tumpey TM, Basler CF, Taubenberger JK, Palese P: A single amino acid substitution in 1918 influenza virus hemagglutinin changes receptor binding specificity. J Virol 2005;79:11533-11536.
52. Tumpey TM, Maines TR, Van Rooijen N, Glaser L, Solorzano A, Pappas C, Cox NJ, Swayne DE, Palese P, Katz JM, Garcia-Sastre A: A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 2007;315:655-659.
53. Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P, Henklein P, Bennink JR, Yewdell JW: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001;7:1306-1312.
54. Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW: The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J Virol 2003;77:7214-7224.
55. Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005;1:e4.
56. Zamarin D, Ortigoza MB, Palese P: Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 2006;80:7976-7983.
57. Donald HB, Isaacs A: Counts of influenza virus particles. J Gen Microbiol 1954;10:457-464.
58. Duhaut SD, McCauley JW: Defective RNAs inhibit the assembly of influenza virus genome segments in a segment-specific manner. Virology 1996;216: 326-337.
59. Odagiri T, Tashiro M: Segment-specific noncoding sequences of the influenza virus genome RNA are involved in the specific competition between defective interfering RNA and its progenitor RNA segment at the virion assembly step. J Virol 1997;71: 2138-2145.
60. Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y: Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci USA 2003; 100:2002-2007.
61. Fujii K, Fujii Y, Noda T, Muramoto Y, Watanabe T, Takada A, Goto H, Horimoto T, Kawaoka Y: Importance of both the coding and the segmentspecific noncoding regions of the influenza A virus NS segment for its efficient incorporation into virions. J Virol 2005;79:3766-3774.
62. Muramoto Y, Takada A, Fujii K, Noda T, Iwatsuki-Horimoto K, Watanabe S, Horimoto T, Kida H, Kawaoka Y: Hierarchy among viral RNA (vRNA) segments in their role in vRNA incorporation into influenza A virions. J Virol 2006;80:2318-2325.
63. Watanabe T, Watanabe S, Noda T, Fujii Y, Kawaoka Y: Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol 2003;77: 10575-10583.
64. Liang Y, Hong Y, Parslow TG: cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol 2005;79:10348-10355.
65. Belshe RB, Nichol KL, Black SB, Shinefield H, Cordova J, Walker R, Hessel C, Cho I, Mendelman PM: Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5-49 years. Clin Infect Dis 2004; 39:920-927.
66. Chen Z, Aspelund A, Kemble G, Jin H: Genetic mapping of the cold-adapted phenotype of B/Ann Arbor/1/66, the master donor virus for live attenuated influenza vaccines (FluMist). Virology 2006;345: 416-423.
67. Hoffmann E, Mahmood K, Chen Z, Yang CF, Spaete J, Greenberg HB, Herlocher ML, Jin H, Kemble G: Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66. J Virol 2005;79:11014-11021.
68. Jin H, Lu B, Zhou H, Ma C, Zhao J, Yang CF, Kemble G, Greenberg H: Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60. Virology 2003;306:18-24.
69. Jin H, Zhou H, Lu B, Kemble G: Imparting temperature sensitivity and attenuation in ferrets to A/Puerto Rico/8/34 influenza virus by transferring the genetic signature for temperature sensitivity from cold-adapted A/Ann Arbor/6/60. J Virol 2004; 78:995-998.
70. Quinlivan M, Zamarin D, Garcia-Sastre A, Cullinane A, Chambers T, Palese P: Attenuation of equine influenza viruses through truncations of the NS1 protein. J Virol 2005;79:8431-8439.
71. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, Garcia-Sastre A, Palese P: Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci USA 2000;97: 4309-4314.
72. Watanabe T, Watanabe S, Kida H, Kawaoka Y: Influenza A virus with defective M2 ion channel activity as a live vaccine. Virology 2002;299:266-270.
73. Koopmans M, Wilbrink B, Conyn M, Natrop G, van der Nat H, Vennema H, Meijer A, van Steenbergen J, Fouchier R, Osterhaus A, Bosnian A: Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004;363:587-593.
74. Peiris M, Yuen KY, Leung CW, Chan KH, Ip PL, Lai RW, Orr WK, Shortridge KF: Human infection with influenza H9N2. Lancet 1999;354:916-917.
75. Tweed SA, Skowroski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, Halpert C, Hirst M, Astell C, Lawrence D, Mak A: Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 2004;10:2196-2199.
76. Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R: Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (HlNl) vaccines comprised of egg- or cell culture-derived reassortants. Virus Res 2004;105:183-194.
77. Bruhl P, Kerschbaum A, Kistner O, Barrett N, Dorner F, Gerencer M: Humoral and cell-mediated immunity to Vero cell-derived influenza vaccine. Vaccine 2000;19:1149-1158.
78. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Dorner F: Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998;16:960-968.
79. Kistner O, Barrett PN, Mundt W, Reiter M, SchoberBendixen S, Eder G, Dorner F: Development of a Vero cell-derived influenza whole virus vaccine. Dev Biol Stand 1999;98:101-110.
80. Kistner O, Barrett PN, Mundt W, Reiter M, Schober-Bendixen S, Eder G, Dorner F: A novel mammalian cell (Vero) derived influenza virus vaccine: development, characterization and industrial scale production. Wien Klin Wochenschr 1999;111: 207-214.
81. Nicolson C, Major D, Wood JM, Robertson JS: Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005; 23:2943-2952.
82. Kawaoka Y, Webster RG: Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc Natl Acad Sci USA 1988;85:324-328.
83. Garten W, Klenk HD: Understanding influenza virus pathogenicity. Trends Microbiol 1999;7:99-100.
84. Horimoto T, Kawaoka Y: Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J Virol 1994;68:3120-3128.
85. Horimoto T, Takada A, Fujii K, Goto H, Hatta M, Watanabe S, Iwatsuki-Horimoto K, Ito M, TagawaSakai Y, Yamada S, Ito H, Ito T, Imai M, Itamura S, Odagiri T, Tashiro M, Lim W, Guan Y, Peiris M, Kawaoka Y: The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine 2006;24:3669-3676.
86. Lin J, Zhang J, Dong X, Fang H, Chen J, Su N, Gao Q, Zhang Z, Liu Y, Wang Z, Yang M, Sun R, Li C, Lin S, Ji M, Liu Y, Wang X, Wood J, Feng Z, Wang Y, Yin W: Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 2006;368:991-997.
87. Bresson JL, Perronne C, Launay O, Gerdil C, Saville M, Wood J, Hoschler K, Zambon MC: Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 2006;367:1657-1664.
88. Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M: Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006;354:1343-1351.
89. Suguitan AL, McAuliffe J, Mills KA, Jin H, Duke G, Lu B, Luke CJ, Murphy B, Swayne DE, Kemble G, Subbarao K: Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006;3:e360.
90. Maeda Y, Hatta M, Takada A, Watanabe T, Goto H, Neumann G, Kawaoka Y: Live bivalent vaccine for parainfluenza and influenza virus infections. J Virol 2005;79:6674-6679.